IE33502B1 - Analgesic compositions - Google Patents
Analgesic compositionsInfo
- Publication number
- IE33502B1 IE33502B1 IE1066/69A IE106669A IE33502B1 IE 33502 B1 IE33502 B1 IE 33502B1 IE 1066/69 A IE1066/69 A IE 1066/69A IE 106669 A IE106669 A IE 106669A IE 33502 B1 IE33502 B1 IE 33502B1
- Authority
- IE
- Ireland
- Prior art keywords
- methyl
- phenoxyphenyl
- hydrogen
- analgesic
- agent
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- -1 phenoxyphenyl compound Chemical class 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 239000004084 narcotic analgesic agent Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- YBCPYHQFUMNOJG-UHFFFAOYSA-N metofoline Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(C)C1CCC1=CC=C(Cl)C=C1 YBCPYHQFUMNOJG-UHFFFAOYSA-N 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 2
- 230000003389 potentiating effect Effects 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- CQWOKJLMSWMOCJ-UHFFFAOYSA-N 2-(4-phenoxyphenyl)propanoic acid Chemical class C1=CC(C(C(O)=O)C)=CC=C1OC1=CC=CC=C1 CQWOKJLMSWMOCJ-UHFFFAOYSA-N 0.000 abstract 1
- VFUGCQKESINERB-UHFFFAOYSA-N 3-(1-methyl-3-propylpyrrolidin-3-yl)phenol Chemical compound C=1C=CC(O)=CC=1C1(CCC)CCN(C)C1 VFUGCQKESINERB-UHFFFAOYSA-N 0.000 abstract 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical class NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 229950009818 metofoline Drugs 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 239000012457 nonaqueous media Substances 0.000 abstract 1
- 229960000482 pethidine Drugs 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75278768A | 1968-08-15 | 1968-08-15 | |
| US75278868A | 1968-08-15 | 1968-08-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33502L IE33502L (en) | 1970-02-15 |
| IE33502B1 true IE33502B1 (en) | 1974-07-24 |
Family
ID=27115647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1066/69A IE33502B1 (en) | 1968-08-15 | 1969-07-31 | Analgesic compositions |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE737415A (enExample) |
| CA (1) | CA974451A (enExample) |
| CY (1) | CY782A (enExample) |
| DE (1) | DE1941583C3 (enExample) |
| FR (1) | FR2015729B1 (enExample) |
| GB (1) | GB1250582A (enExample) |
| IE (1) | IE33502B1 (enExample) |
| IL (1) | IL32781A (enExample) |
| LU (1) | LU59283A1 (enExample) |
| MY (1) | MY7500035A (enExample) |
| NL (1) | NL161669C (enExample) |
| SE (1) | SE374269B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU528532B2 (en) * | 1978-12-18 | 1983-05-05 | Mcniel Laboratories | Acetaminophen analgesic potentiation |
| EP0068838B1 (en) * | 1981-06-26 | 1986-09-17 | The Upjohn Company | Analgesic process and composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU38115A1 (enExample) * | 1959-01-07 |
-
1969
- 1969-07-31 IE IE1066/69A patent/IE33502B1/xx unknown
- 1969-08-05 IL IL32781A patent/IL32781A/xx unknown
- 1969-08-12 SE SE6911179A patent/SE374269B/xx unknown
- 1969-08-13 CA CA059,407A patent/CA974451A/en not_active Expired
- 1969-08-13 BE BE737415D patent/BE737415A/xx unknown
- 1969-08-13 LU LU59283D patent/LU59283A1/xx unknown
- 1969-08-14 CY CY782*UA patent/CY782A/xx unknown
- 1969-08-14 GB GB1250582D patent/GB1250582A/en not_active Expired
- 1969-08-14 FR FR6928043A patent/FR2015729B1/fr not_active Expired
- 1969-08-15 NL NL6912502.A patent/NL161669C/xx not_active IP Right Cessation
- 1969-08-16 DE DE1941583A patent/DE1941583C3/de not_active Expired
-
1975
- 1975-12-30 MY MY35/75A patent/MY7500035A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA974451A (en) | 1975-09-16 |
| SE374269B (enExample) | 1975-03-03 |
| FR2015729A1 (enExample) | 1970-04-30 |
| NL161669C (nl) | 1980-03-17 |
| DE1941583C3 (de) | 1980-06-04 |
| DE1941583A1 (de) | 1970-07-09 |
| LU59283A1 (enExample) | 1970-02-13 |
| IL32781A0 (en) | 1969-12-31 |
| MY7500035A (en) | 1975-12-31 |
| DE1941583B2 (de) | 1979-08-23 |
| NL161669B (nl) | 1979-10-15 |
| NL6912502A (enExample) | 1970-02-17 |
| BE737415A (enExample) | 1970-02-13 |
| CY782A (en) | 1975-03-01 |
| FR2015729B1 (enExample) | 1974-02-01 |
| GB1250582A (enExample) | 1971-10-20 |
| IL32781A (en) | 1974-01-14 |
| IE33502L (en) | 1970-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1518364A (en) | Pharmaceutical composition | |
| EP0214659A3 (en) | Peptide derivatives, process for the production thereof and pharmaceutical compositions containing same | |
| IE33502L (en) | Analgesic composition | |
| DE3568440D1 (en) | New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
| GB1256750A (enExample) | ||
| GB1513646A (en) | Analgesic compositions | |
| JPS552601A (en) | Anti-tumor agent for non-injection use | |
| IT1253703B (it) | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie | |
| IE35569L (en) | 2-phenyl-5-aminodiazole derivatives | |
| IE812944L (en) | Pyrazoline derivatives | |
| GB1114660A (en) | Tetrahydro-lsoquinolines | |
| EP0030023A3 (en) | A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine | |
| GB1334693A (en) | Acenaphthene derivatives | |
| JPS5592341A (en) | Preparation of clathrate compound | |
| GB1280386A (en) | Anti-fertility agents | |
| IE33542B1 (en) | Analgesic compositions | |
| US3968145A (en) | Methyl 2(1 chloronaphth-2-yloxy)propionate | |
| GB1278040A (en) | New analgesic composition having enhanced activity | |
| GB1276719A (en) | Benzomorphan derivatives and their salts | |
| GB1220793A (en) | Pharmaceutical compositions | |
| KR860000257A (ko) | 무통각 활성을 지닌 피롤카르복실산 유도체의 제조방법 및 이것을 함유한 약학적 조성물 | |
| GB1504683A (en) | Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives | |
| IE34261L (en) | 1, 2-diphenyl-3, 5-dioxo-4 substituted pyrazolidines | |
| GB1374328A (en) | Pharmaceutically active propanopiperidine derivatives | |
| IE34386L (en) | Acetylsalicylic acid-containing composition |